| |
|
|
|
Eyepoint Pharmaceuticals Inc  
|
|
0.5637 0.03 (0.06%) |
09-25 16:00 |
|
Open: |
0.54 |
Pre close: |
0.5333 |
Target:
|
0.90
|
|
High: |
0.6 |
Low: |
0.5252 |
Resistance:
|
0.77
0.96
|
|
Volume: |
920,467 |
Market Cap: |
71M |
Support:
|
0.46
0.38
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.56
 |
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
0.53 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.71 |
Stochastic Oscillator |
%K(14,3):
|
52.85 |
|
MA(250): |
1.20 |
%D(3): |
57.20 |
|
Average Volume(K) |
3-Month: |
223005
|
52-Week |
High:
|
2.69 |
|
10-Days: |
61736 |
Low: |
0.46 |
|
RSI |
RSI(14):
|
49.91 |
Change(%): |
-68.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.458 |
Return on Equity (ttm) |
-322.1 |
Shares Out. (M) |
125.22 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-35.0 |
Shares Float (M) |
81.91 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.82 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-42.8 |
% Held by Institutions |
53.74 |
|
Forward EPS |
-0.540 |
Gross Profit (p.s.) |
0.018 |
Shares Short (K) |
2210 |
|
Book Value (p.s.) |
0.030 |
EBITDA (p.s.) |
-0.339 |
P/E |
-1.23 |
|
Sales Per Share |
0.182 |
Qtrly Earnings Growth |
0.00 |
P/BV |
18.79 |
|
Profit Margin |
-229.33 |
Operating Cash Flow
(M) |
-47.72 |
P/S |
3.10 |
|
Operating Margin |
-197.99 |
Levered Free Cash Flow
(M) |
-29.53 |
P/CF |
-1.48 |
|
|
|
|
|
|
